Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1

Conditions

Neoplasms 2Melanoma 2Thyroid Diseases 1Stomach Neoplasms 1Skin Neoplasms 1Neuroma, Acoustic 1Lung Neoplasms 1Gastrointestinal Stromal Tumors 1Gastrointestinal Diseases 1Endometrial Neoplasms 1Brain Neoplasms 1Adenolymphoma 1

Interventions

selpercatinib 2Sorafenib 2vandetanib 1temsirolimus 1pralsetinib 1pembrolizumab 1lenvatinib 1cabozantinib 1Vitamin B 12 1Thyrotropin-Releasing Hormone 1Technetium Tc 99m Sestamibi 1Pemetrexed 1Panobinostat 1NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt 1Metformin 1Folic Acid 1Fluorescein 1Cisplatin 1Cetuximab 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Thyroid Diseases × Fluorescein × Clear all
NCT06054178 2026-05-20

Identification of Nerves Using Fluorescein Sodium

Stanford University

Phase 2 Completed
8 enrolled 9 charts
Head & NeckLymphoid

Adenolymphoma, Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡